Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$701,362
+$55,665 QoQ
Shares Held
14,630
-16.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#616
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MMBG INVESTMENT ADVISORS CO. holds $24,468,004 across 8 Drug Manufacturers - General names. NVO ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,070 | $10,878,831 | |
| 2 | ABBV |
AbbVie Inc.
|
17,115 | $4,306,818 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,563 | $2,899,345 | |
| 4 | AZN |
Astrazeneca PLC
|
13,514 | $2,562,524 | |
| 5 | AMGN |
Amgen Inc
|
6,044 | $2,188,653 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
14,630 | $701,362 | |
| 7 | JNJ |
Johnson & Johnson
|
2,602 | $660,829 | |
| 8 | BIIB |
Biogen Inc.
|
1,248 | $269,642 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $701,362 | 14,630 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $645,697 | 17,570 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,513,934 | 29,755 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,755,259 | 31,632 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,295,743 | 33,262 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,082,158 | 29,985 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,519,543 | 17,665 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||